Cite
HARVARD Citation
Seufert, J. et al. (n.d.). P2857Increase in pulse rate with semaglutide did not result in increased adverse cardiac events in subjects with type 2 diabetes in the SUSTAIN 6 cardiovascular outcomes trial. European heart journal. p. . [Online].